Allogeneic stem cell transplantation in AML with t(6;9)(p23;q34);DEK-NUP214 shows a favourable outcome when performed in first complete remission

scientific article published on 05 February 2020

Allogeneic stem cell transplantation in AML with t(6;9)(p23;q34);DEK-NUP214 shows a favourable outcome when performed in first complete remission is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/BJH.16433
P698PubMed publication ID32020596

P50authorLiisa VolinQ53381572
Nicolaas SchaapQ57161901
Marina Díaz-BeyáQ58375667
Jakob R. PasswegQ67905482
Mohamad MohtyQ86836425
Jorge SierraQ87668659
Jordi EsteveQ87668661
Dietrich W BeelenQ89402080
Johan MaertensQ89490552
Myriam LabopinQ89534568
Harry SchoutenQ89534570
Gerard SociéQ89534572
Mauricette MichalletQ89534574
Emmanuelle PolgeQ89534576
Arnon NaglerQ89534579
Rainer SchwerdtfegerQ114426804
P2093author name stringAcute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)
Mahmoud Alijurf
P921main subjectstem cell transplantationQ65592366
P577publication date2020-02-05
P1433published inBritish Journal of HaematologyQ4970200
P1476titleAllogeneic stem cell transplantation in AML with t(6;9)(p23;q34);DEK-NUP214 shows a favourable outcome when performed in first complete remission

Search more.